Journal Article10.2174/1381612826666200531151004
Exploring Potential of Alkaloidal Phytochemicals Targeting Neuroinflammatory Signaling of Alzheimer's Disease.
Sahab Uddin,Tanvir Kabir,Abdullah Al Mamun,Tapan Behl,Rasha A. Mansouri,Akram Ahmed Aloqbi,Asma Perveen,Abdul Hafeez,Ghulam Md Ashraf +8 more
15
TL;DR: This review focuses on the link of neuroinflammation in AD as well as highlight the probable mechanisms of alkaloidal phytochemicals to combat neuroinflammatory aspect of AD.
read more
Abstract: Alzheimer's disease (AD) is a chronic neurodegenerative disorder that is marked by cognitive dysfunctions and the existence of neuropathological hallmarks such as amyloid plaques, and neurofibrillary tangles. It has been observed that a persistent immune response in the brain has appeared as another neuropathological hallmark in AD. The sustained activation of the microglia, the brain's resident macrophages, and other immune cells has been shown to aggravate both tau and amyloid pathology and may consider as a connection in the AD pathogenesis. However, the basic mechanisms that link immune responses in the pathogenesis of AD are unclear until now since the process of neuroinflammation can have either a harmful or favorable effect on AD, according to the phase of the disease. Numerous researches recommend that nutritional fruits, as well as vegetables, possess neurodefensive properties against the detrimental effects of neuroinflammation and aging. Moreover, these effects are controlled by diverse phytochemical compounds that are found in plants and demonstrate anti-inflammatory, neuroprotective, as well as other beneficial actions. In this review, we focus on the link of neuroinflammation in AD as well as highlight the probable mechanisms of alkaloidal phytochemicals to combat the neuroinflammatory aspect of AD.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration.
Md. Sahab Uddin,Abdullah Al Mamun,Md. Tanvir Kabir,Jamil Ahmad,Philippe Jeandet,Md. Shahid Sarwar,Ghulam Md Ashraf,Lotfi Aleya +7 more
TL;DR: The potential efficacy ofpolyphenols such as epigallocatechin-3-gallate, curcumin, resveratrol, quercetin and methylated polyphenols berberine against the most common neurodegenerative disorders is focused on.
96
The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease
Tan Sook Ling,Shanthini Chandrasegaran,Low Zhi Xuan,Tong Li Suan,Elaine Elaine,Durrgashini Visva Nathan,Yam Hok Chai,Baskaran Gunasekaran,Shamala Salvamani +8 more
TL;DR: In this paper, the authors discuss the advancement of nanotechnology which helps in the diagnosis and treatment of neurodegenerative disorders such as Alzheimer's disease as well as its challenges.
Exploring the Role of CLU in the Pathogenesis of Alzheimer’s Disease
TL;DR: The critical interaction of CLU and AD is represented based on recent advances and the Aβ-dependent and A β-independent mechanisms by which CLU plays a role in AD pathogenesis are focused on.
18
Exploring the Role of Monoamine Oxidase Activity in Aging and Alzheimer's Disease.
Sohanur Rahman,Sahab Uddin,Ataur Rahman,Samsuzzaman,Tapan Behl,Abdul Hafeez,Asma Perveen,George E. Barreto,Ghulam Md Ashraf +8 more
TL;DR: In this paper, a review describes the pathogenic mechanism of MAOs in aging as well as the development and propagation of Alzheimer's pathology, which is a progressive neurodegenerative disorder associated with an excessive accumulation of amyloid-beta (Aβ) peptide and neurofibrillary tangles.
18
History in Perspective: The prime pathological players and role of phytochemicals in Alzheimer’s disease
TL;DR: In this article , the formation and crosstalk between amyloid and tau pathologies as well as the effect of neuroinflammation on the progression of Alzheimer's disease are discussed.
14
References
Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
Oscar P. Dall'Igna,Paulo Fett,Marcio Walace Santos Gomes,Diogo O. Souza,Rodrigo A. Cunha,Diogo R. Lara +5 more
TL;DR: First direct in vivo evidence that caffeine and A(2A) receptor antagonists afford a protection against Abeta-induced amnesia, which prompts their interest for managing Alzheimer's disease is provided.
Chronic Psychosocial Stress Exacerbates Impairment of Synaptic Plasticity in β-Amyloid Rat Model of Alzheimers Disease: Prevention by Nicotine
TL;DR: Investigation of the effect of chronic psychosocial stress on synaptic plasticity in the β-Amyloid rat model of AD revealed that stress and/or Aβ significantly increased the basal levels of calcineurin and prevented the expected L-LTP-induced increase in CREB phosphorylation, and CaMKIV levels.
Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study.
B.M. van Gelder,Brian Buijsse,M.J. Tijhuis,S. Kalmijn,Simona Giampaoli,A. Nissinen,Daan Kromhout +6 more
TL;DR: Findings suggest that consuming coffee reduces cognitive decline in elderly men, and an inverse and J-shaped association may exist between the number of Cups of coffee consumed and cognitive decline, with the least cognitive decline for men consuming three cups of coffee per day.
Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.
Cyril Laurent,Cyril Laurent,Sabiha Eddarkaoui,Sabiha Eddarkaoui,Maxime Derisbourg,Maxime Derisbourg,Antoine Leboucher,Antoine Leboucher,Dominique Demeyer,Dominique Demeyer,Sébastien Carrier,Sébastien Carrier,Marion Schneider,Malika Hamdane,Malika Hamdane,Christa E. Müller,Luc Buée,Luc Buée,David Blum,David Blum +19 more
TL;DR: It is found that chronic caffeine intake prevents from the development of spatial memory deficits in tau mice, and in vivo effects of caffeine in a model of AD-like tauopathy remain unknown.
Spectrum of Disease and Prescription Pattern for Outpatients with Neurological Disorders: An Empirical Pilot Study in Bangladesh.
Sahab Uddin,Abdullah Al Mamun,Asaduzzaman,Fakhrul Hosn,Mohammad Abu Sufian,Shinya Takeda,Oscar Herrera-Calderon,Mohamed M. Abdel-Daim,G. M. Sala Uddin,Ali Asif Noor,Mst. Marium Begum,Tanvir Kabir,Sonia Zaman,Shahid Sarwar,Mosiqur Rahman,Rajdoula Rafe,Farhad Hossain,Sarwar Hossain,Mohammed Ashraful Iqbal,Ataur Rahman Sujan +19 more
TL;DR: Examination of the prevalence and prescription pattern for outpatients with neurological disorders in Bangladesh found that neurological diseases are more prevalent than other different diseases among different age groups and genders.